State of Wisconsin Investment Board
TPTX

State of Wisconsin Investment Board’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

State of Wisconsin Investment Board’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-45,955
Closed -$3.46M – 2835
2022
Q2 		$3.46M Sell
45,955
-31,745
-41% -$1.41M 0.01% 1171
2022
Q1 		$2.09M Buy
77,700
+18,200
+31% +$612K ﹤0.01% 1485
2021
Q4 		$2.84M Hold
59,500
– – 0.01% 1181
2021
Q3 		$3.95M Hold
59,500
– – 0.01% 1105
2021
Q2 		$4.64M Buy
59,500
+5,900
+11% +$436K 0.01% 1071
2021
Q1 		$5.07M Sell
53,600
-600
-1% -$71.3K 0.01% 1014
2020
Q4 		$6.6M Buy
54,200
+5,300
+11% +$581K 0.02% 878
2020
Q3 		$4.27M Buy
48,900
+5,900
+14% +$411K 0.01% 983
2020
Q2 		$2.78M Buy
43,000
+200
+0.5% +$11.5K 0.01% 1052
2020
Q1 		$1.91M Buy
42,800
+32,800
+328% +$1.74M 0.01% 1073
2019
Q4 		$623K Hold
10,000
– – ﹤0.01% 1368
2019
Q3 		$376K Buy
+10,000
New +$435K ﹤0.01% 1411

State of Wisconsin Investment Board's TPTX Position: Q3 2022 in Review

State of Wisconsin Investment Board sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 45,955 shares — an estimated $3.46M sold.

State of Wisconsin Investment Board first reported a position in TPTX in Q3 2019 and held it in 12 quarters. The position peaked at $6.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • State of Wisconsin Investment Board reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 45,955 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $3.46M.
  • State of Wisconsin Investment Board first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 12 quarters.
  • State of Wisconsin Investment Board's Turning Point Therapeutics, Inc. Common Stock position peaked at $6.6M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2022, filed 14 Nov 2022.